Central Nervous System Therapeutics Market Report Forecast 2024

1. 1

2. Market Overview: The global central nervous system therapeutics market size was valued at USD 133.8 billion in 2023 and is poised to grow at a significant CAGR of 7.4% during the forecast period 2024-30. The central nervous system therapeutics market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the central nervous system therapeutics market analysis from 2024 to 2030 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

3. Market Segments: The central nervous system therapeutics market has been fragmented based on: 1) By Disease Type: Neurovascular Diseases, Trauma, Mental Health, Degenerative Disease, Infectious Diseases, Cancer, and Others 2) By Drug Class: Analgesics, Antidepressants, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, and Others 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Request Sample Report 3

4. Key Players: Some of the major key players in the central nervous system therapeutics market are: Pfizer Biogen Inc. Johnson & Johnson Services Inc. Eli Lilly and Company Inc. Teva Pharmaceutical Industries Ltd. Shire Plc Allergan Plc. Request Sample Report 4

5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5